Skip to content

A prospective, randomized, and self-controlled study on the effect of periorbital swelling and ecchymosis regression after rhinoplasty with periorbital adhesive application at different time points

A prospective, randomized, and self-controlled study on the effect of periorbital swelling and ecchymosis regression after rhinoplasty with periorbital adhesive application at different time points

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031761
Enrollment
Unknown
Registered
2020-04-09
Start date
2020-04-15
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periorbital swelling and ecchymosis

Interventions

2 days group:adhesive tape for 2 days
3 days group:adhesive tape for 3 days
7 days group:adhesive tape for 7 days

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. There is a need for rhinoplasty, preoperative diagnosis is clear, in line with augmentation rhinoplasty and other indications; 2. Beauty seekers are in normal mental state and have no physical disorder; 3. Beauty seekers who have never had rhinoplasty before; 4. After knowing all the treatment options and risks, beauty seekers who voluntarily signed the informed consent and was willing to accept the self-controlled test and cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: 1. Beauty seekers with a history of hypertension and a long history of smoking; 2. Beauty seekers with coagulation dysfunction related diseases and a long history of taking anticoagulant drugs; 3. Beauty seekers with wound epidermal rupture or local molting in the lesion area; 4. Beauty seekers are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
VAS;

Secondary

MeasureTime frame
Adverse reaction;

Countries

China

Contacts

Public ContactPeng xu

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine

xupeng3243724@163.com+86 18817821572

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026